TTF1 EXPRESSION IN ADVANCED NON-SMALL CELL LUNG CANCER: IMPACT ON SURVIVAL OUTCOME

被引：0
|
作者：
Elsamany, S. [1 ]
Al-fayea, T. [2 ]
Abozeed, W. N. [3 ]
Alzahrani, A. [4 ]
Farooq, M. U. [5 ]
Darwish, W. [2 ]
Almadani, A. [6 ]
Bukhari, E. [6 ]
机构：
[1] Mansoura Univ, Ctr Oncol, Med Oncol, Mansoura, Egypt
[2] King Abdulaziz Med City KAMC Jeddah Princess Nour, Oncol, Jeddah, Saudi Arabia
[3] Mansoura Univ Hosp, Clin Oncol, Mansoura, Egypt
[4] King Abdullah Med City, Oncol, Mecca, Saudi Arabia
[5] King Abdullah Med City, Res, Mecca, Saudi Arabia
[6] Um Alqora Univ, Res, Mecca, Saudi Arabia
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
10.1093/annonc/mdv050.40
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
136P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Proliferative activity and TTF-1 expression in non-small cell lung carcinomas
    Puglisi, F
    Aprile, G
    Bruckbauer, M
    Di Loreto, C
    ANNALS OF ONCOLOGY, 2000, 11 : 10 - 10
  • [32] Outcome of elderly patients with advanced non-small cell lung cancer.
    Gumus, M
    Palak, B
    Iyikesici, S
    Yumuk, PF
    Seker, M
    Topal, A
    Dane, F
    Salepci, T
    Yayla, A
    Turhal, NS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 706S - 706S
  • [33] Expression of Estrogen Receptor-α and Survival in Advanced-stage Non-small Cell Lung Cancer
    Lund-Iversen, Marius
    Scott, Helge
    Strom, Erik H.
    Theiss, Noah
    Brustugun, Odd Terje
    Gronberg, Bjorn H.
    ANTICANCER RESEARCH, 2018, 38 (04) : 2261 - 2269
  • [34] Impact of novel agent therapy on survival of patients with advanced non-small cell lung cancer in Lebanon
    Massoud, M. A.
    Azar, K.
    Zeghondy, J. Z.
    Akoury, E.
    Makdessi, J.
    Sakr, R.
    ANNALS OF ONCOLOGY, 2022, 33 : S1579 - S1579
  • [35] Survival benefits associated with surgery for advanced non-small cell lung cancer
    David, Elizabeth A.
    Andersen, Stina W.
    Beckett, Laurel A.
    Melnikow, Joy
    Clark, James M.
    Brown, Lisa M.
    Cooke, David T.
    Kelly, Karen
    Canter, Robert J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (04): : 1620 - 1628
  • [36] TTF-1 and immune checkpoint therapy in non-small cell lung cancer
    Gumbleton, Matthew
    Snyder, Eric L.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 398 - 400
  • [37] Clinical Impact of Interstitial Lung Disease on Advanced Non-Small Cell Lung Cancer
    Oi, H.
    Taniguchi, H.
    Kondoh, Y.
    Kimura, T.
    Kataoka, K.
    Matsuda, T.
    Yokoyama, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2082 - S2082
  • [38] Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Kurishima, Koichi
    Nakamura, Ryota
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Ohara, Gen
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2009, 29 (07) : 2671 - 2674
  • [39] PD-L1 expression is associated with advanced non-small cell lung cancer
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Wang, Guochen
    Li, Zuosheng
    Hou, Jingpu
    Zhang, Qiuyang
    You, Zongbing
    Zhang, Liu
    ONCOLOGY LETTERS, 2016, 12 (02) : 921 - 927
  • [40] Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer
    Uhlenbruch, Mark
    Krueger, Stefan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (08)
12345